(PDF) Intravitreal Bevacizumab as Single Drug Therapy for

Intravitreal Bevacizumab as Single Drug Therapy for Retinopathy of Prematurity in 12 Patients

Archivos Argentinos de Pediatria - Argentina

doi 10.5546/aap.2014.eng.160

Full Text

Abstract

Available in full text

Categories

Date

February 15, 2014

Authors

Unknown

Publisher

Sociedad Argentina de Pediatria

Related search

Intravitreal Bevacizumab for Retinopathy of Prematurity in Infants Ineligible for Laser Therapy*

Turkish Journal of Medical Sciences

English

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia

English

A Lower Dose of Intravitreal Bevacizumab Effectively Treats Retinopathy of Prematurity

Journal of AAPOS

English

Late Recurrence of Retinopathy of Prematurity After Treatment With Both Intravitreal Bevacizumab and Laser

Journal of AAPOS

English

Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity

English

Low Dose Versus Conventional Dose of Intravitreal Bevacizumab Injection for Retinopathy of Prematurity: A Case Series With Paired-Eye Comparison

Acta Ophthalmologica

English

Beta-Blocker Therapy for Retinopathy of Prematurity

English

Intravitreal Bevacizumab as an Adjunctive Therapy Before Diabetic Vitrectomy

Clinical Ophthalmology

English

Neurodevelopmental Outcomes After Extreme Prematurity Comparing Bevacizumab to Laser Surgery for Type 1 Retinopathy of Prematurity

Developmental Medicine and Child Neurology

Developmental Neuroscience

English